Co-Diagnostics, Inc.
What we do is driven by what we believe. Which is helping create a better quality of life on a large scale. That’s why we are making our revolutionary PCR technology available at cost-efficient pricing around the world. No matter your geography and socioeconomic status, we believe you deserve an accurate test that allows you to act rather than react. Our proprietary molecular diagnostics technology is paving the way for innovation in disease detection and life sciences research through our enhanced detection of genetic material. When your doctor or health care provider chooses a Co-Dx test, they are providing you peace of mind.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Globally (various continents)
- Year Founded:
- 2013
About Us
Disrupting molecular diagnostics’ status quo
The PCR testing revolution starts and ends with accuracy and affordability. And our technology works to reliably, accurately and affordably detect infectious diseases—which leads to quicker treatment and recovery, increased peace of mind and even lives saved. See how we’re making our tech accessible to all.
Trust your results.
When it comes to disease testing, the speed and accuracy of results can dramatically improve outcomes and lead to good decision making. At Co-Dx, our solutions are:
Innovative
The revolutionary, game-changing technology we’ve brought to life is the result of a tenacious effort to improve lives.
Compassionate
We believe everyone should have access to reliable, accurate diagnostic testing technology at an affordable price.
Simple
We have a unique ability to create complex technology and render it in elegant products at affordable prices around the world.
Modern
Being at the forefront of the PCR testing industry takes intelligence and innovation. Staying there takes relentless drive. We’re committed to staying ahead of the curve.
Our Vision
The best technology changes lives. It can even save them. We believe the benefits of affordable, high-quality molecular diagnostics should be available to all.
CoSara Diagnostics Private Limited
Our global partners include Asence Inc, a U.S. incorporated company specializing in supplying pharmaceutical products to international markets. CODX has a Joint Venture agreement for manufacturing with Synbiotics Ltd, a group company of Asence Inc.
CoSara has the exclusive manufacturing rights in India for the complete menu of Co-Diagnostics infectious disease molecular diagnostics kits, engineered using Co-Diagnostics’ proprietary design process and patented CoPrimer™ technology. CoSara was incorporated in 2017, and its 2,500 sq ft Good Manufacturing Practices (GMP) facility is one of the first of its kind in India for manufacturing in vitro diagnostics designated for clinical use.
The JV facility in Ranoli, India was inaugurated in April 2019 to manufacture CODX-designed products under the label CoSara Diagnostics, Pvt., Ltd according to internationally-recognized Current Good Manufacturing Practices (“cGMP”) standards. In December 2019, CoSara received approval by the Central Drug Standard Control Organization (“CDSCO”) for the following in vitro diagnostics:
- Mycobacterium tuberculosis
- Malaria
- Hepatitis B
- Hepatitis C
- Human papillomavirus (HPV)
The website for CoSara Diagnostics may be found here